The July Issue of the #RedJournal is here! Explore the issue, including the NEW ACG Guidelines on Acute Liver Failure, plus articles on cyclic vomiting syndrome, H. pylori, hepatitis B, biologics in IBD, EHR burden & much more.
Author: Abhay Panchal
Patients suffering from IBS, NASH, GERD, dysphagia and other common GI disorders can be a challenge to diagnose and treat. The 2023 Principles of GI for the NP and PA, which will take place Aug. 18-20, in Denver, Colorado, and online, guides advanced practice providers (APPs) on how to address these diseases through case-based scenarios often seen in practice. Save $100 by registering through Aug. 4.
Here are 10 moves from three major gastroenterology groups that Becker’s has reported in the second quarter of 2023: GI Alliance
The nation’s most profitable insurer has yet to release clear information about its new program that went into effect on June 1, which lays the groundwork for UHC’s prior authorization policy for lifesaving colonoscopies and endoscopies. The American Gastroenterological Association (AGA) remains concerned by UnitedHealthcare’s (UHC) advance notification program, which went into immediate effect June 1. The nation’s most profitable insurer has yet to provide clear requirements, instructions or training––sowing confusion and uncertainty among doctors and their staff. Most importantly, AGA remains alarmed that the insurance giant is using this program as a basis for its “Gold Card” prior authorization…
The largest physician group in the U.S. has nearly 14,000 doctors, according to a new analysis from Definitive Healthcare provided to MedPage Today. Physician groups come in many varieties, from large health system-affiliated groups to contract management groups to small practices owned by physicians. Definitive Healthcare says it tracks more than 125,000 such groups — but the top 20 are mostly dominated by those run by large health systems.
Private medical practices are a hot commodity right now as private equity firms narrow their focus on merger and acquisition (M&A) opportunities. With medical services continuing to shift from hospital environments to outpatient facilities, health care investors are looking for practices that can expand their current network and capabilities. In fact, 60% of health care investors surveyed by KPMG said they expect M&A activity to increase this year.
Abstract: Barrett esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), a cancer that continues to have a poor 5-year survival rate of 20%. Current BE screening strategies aim to detect BE and EAC at early, curable stages, but the majority of patients with EAC are diagnosed outside of BE screening and surveillance programs. Guidelines around the world suggest screening for BE in patients with gastroesophageal reflux disease (GERD) and additional demographic and clinical risk factors using high-definition white-light endoscopy (HDWLE). However, current strategies relying on HDWLE are problematic with high direct and indirect costs, procedural risks, and…
TOPLINE:The risk for allergic disorders, especially eosinophilic esophagitis (EoE), is significantly higher in people with achalasia, suggesting the need for an EoE evaluation before embarking on invasive achalasia treatment, researchers say. METHODOLOGY:
Exercise training is crucial in managing nonalcoholic fatty liver disease (NAFLD), but its ability to significantly improve liver fat remains uncertain. For a study, researchers sought to investigate the association between exercise training and the attainment of validated thresholds for MRI-measured treatment response. Through March 2022, randomized controlled trials involving adults with NAFLD were identified. Exercise training was compared with no exercise training, and the primary outcome was achieving a ≥30% relative reduction in MRI-measured liver fat—a threshold indicative of histologic improvement in nonalcoholic steatohepatitis activity, resolution of nonalcoholic steatohepatitis, and liver fibrosis stage. Different exercise doses were also compared.
Disorders of gut–brain interaction (DGBI) are highly prevalent chronic gastrointestinal symptoms that are categorised into 33 disorders delineated by gastrointestinal anatomic region. 1 DGBI can occur in isolation, but frequently are present in combinations that affect multiple anatomic regions. The coexistence of multiple DBGI in an individual, termed overlap, has been linked to worse disease severity and quality of life. 2 However, the actual prevalence of DGBI overlap and associated features have remained unknown until Thomas Fairlie and colleagues 3 conducted a systematic review and meta-analysis on the topic. Among 46 studies including 75 682 adults with DGBI, the authors found…